Brief: Vericel Publishes Positive Results From Retrospective Study By The BRCA Of Patients With Large Posterior Trunk Burns Treated With Epicel

Vericel

21/07/2022 21:45

July 21 (Reuters) - Vericel Corp  VCEL.O :
    * VERICEL ANNOUNCES PUBLICATION OF POSITIVE RESULTS FROM
RETROSPECTIVE STUDY BY THE BURN AND RECONSTRUCTIVE CENTERS OF
AMERICA (BRCA) OF PATIENTS WITH LARGE POSTERIOR TRUNK BURNS
TREATED WITH EPICEL
    * VERICEL CORP - 83% OF PATIENTS WITH POSTERIOR BURNS HAD
SUCCESSFUL ENGRAFTMENT OF EPICEL AFTER ONE OR TWO APPLICATIONS
    * VERICEL CORP - 90% SURVIVAL RATE FOLLOWING EPICEL AND/OR
EPICEL
PLUS SPLIT THICKNESS SKIN GRAFT
    * VERICEL CORP - STUDY SHOWS STANDARDIZED TREATMENT
PROTOCOLS AND
SURGICAL PLANS FOR EPICEL USE DEVELOPED BY BRCA RESULT IN
POSITIVE PATIENT OUTCOMES

Source text for Eikon:  ID:nGNX7xvdhR 
Further company coverage:  VCEL.O 

 ((Reuters.Briefs@thomsonreuters.com;))